Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shohko Kunimoto is active.

Publication


Featured researches published by Shohko Kunimoto.


Human Molecular Genetics | 2010

Mutations in NOTCH3 cause the formation and retention of aggregates in the endoplasmic reticulum, leading to impaired cell proliferation

Keikichi Takahashi; Kayo Adachi; Kaichi Yoshizaki; Shohko Kunimoto; Raj N. Kalaria; Atsushi Watanabe

Mutations in the human NOTCH3 gene cause cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), but the pathogenic mechanisms of the disorder remain unclear. We investigated the cytotoxic properties of mutant Notch3 using stable cell lines with inducible expression of either wild-type or two mutants p.R133C and p.C185R. We found that both mutants of Notch3 were prone to aggregation and retained in the endoplasmic reticulum (ER). The turnover rates of the mutated Notch3 proteins were strikingly slow, with half-lives greater than 6 days, whereas wild-type Notch3 was rapidly degraded, with a half-life of 0.7 days. The expression of mutant Notch3 also impaired cell proliferation compared with wild-type Notch3. In addition, cell lines expressing mutant Notch3 were more sensitive to proteasome inhibition resulting in cell death. These findings suggest that prolonged retention of mutant Notch3 aggregates in the ER decreases cell growth and increases sensitivity to other stresses. It is also possible that the aggregate-prone property of mutant Notch3 contributes to a pathogenic mechanism underlying CADASIL.


Scientific Reports | 2015

Relationship between social support during pregnancy and postpartum depressive state: a prospective cohort study

Mako Morikawa; Takashi Okada; Masahiko Ando; Branko Aleksic; Shohko Kunimoto; Yukako Nakamura; Chika Kubota; Yota Uno; Ai Tamaji; Norika Hayakawa; Kaori Furumura; Tomoko Shiino; Tokiko Morita; Naoko Ishikawa; Harue Ohoka; Hinako Usui; Naomi Banno; Satomi Murase; Setsuko Goto; Atsuko Kanai; Tomoko Masuda; Norio Ozaki

Although the association between social support and postpartum depression has been previously investigated, its causal relationship remains unclear. Therefore, we examined prospectively whether social support during pregnancy affected postpartum depression. Social support and depressive symptoms were assessed by Japanese version of Social Support Questionnaire (J-SSQ) and Edinburgh Postnatal Depression Scale (EPDS), among 877 pregnant women in early pregnancy and at one month postpartum. First, J-SSQ was standardized among peripartum women. The J-SSQ was found to have a two-factor structure, with Number and Satisfaction subscales, by exploratory and confirmatory factor analyses. Analysis of covariance was performed to examine how EPDS and J-SSQ scores during pregnancy affected the EPDS score at postpartum. Significant associations were found between postpartum EPDS score and both EPDS and total scores on the Number subscales during pregnancy (β = 0.488 and -0.054, ps < 0.001). Specifically, this negative correlation was stronger in depressive than non-depressive groups. Meanwhile, total score on Satisfaction subscales was not significantly associated with postpartum EPDS score. These results suggest that having a larger number of supportive persons during pregnancy helps protect against postpartum depression, and that this effect is greater in depressive than non-depressive pregnant women. This finding is expected to be vitally important in preventive interventions.


Molecular Psychiatry | 2017

High-resolution copy number variation analysis of schizophrenia in Japan

Itaru Kushima; Branko Aleksic; Masahiro Nakatochi; Teppei Shimamura; Tomoko Shiino; Akira Yoshimi; Hiroki Kimura; Yuto Takasaki; Chenyao Wang; Jingrui Xing; Kanako Ishizuka; Tomoko Oya-Ito; Yasuyuki Nakamura; Yuko Arioka; Takuji Maeda; Mitsuko Yamamoto; Mami Yoshida; H Noma; S Hamada; Miyuki Morikawa; Yota Uno; Takashi Okada; Tetsuya Iidaka; Shuji Iritani; Toshimichi Yamamoto; Mitsuhiro Miyashita; Akiko Kobori; Mayumi Arai; Masanari Itokawa; M C Cheng

Recent schizophrenia (SCZ) studies have reported an increased burden of de novo copy number variants (CNVs) and identified specific high-risk CNVs, although with variable phenotype expressivity. However, the pathogenesis of SCZ has not been fully elucidated. Using array comparative genomic hybridization, we performed a high-resolution genome-wide CNV analysis on a mainly (92%) Japanese population (1699 SCZ cases and 824 controls) and identified 7066 rare CNVs, 70.0% of which were small (<100 kb). Clinically significant CNVs were significantly more frequent in cases than in controls (odds ratio=3.04, P=9.3 × 10−9, 9.0% of cases). We confirmed a significant association of X-chromosome aneuploidies with SCZ and identified 11 de novo CNVs (e.g., MBD5 deletion) in cases. In patients with clinically significant CNVs, 41.7% had a history of congenital/developmental phenotypes, and the rate of treatment resistance was significantly higher (odds ratio=2.79, P=0.0036). We found more severe clinical manifestations in patients with two clinically significant CNVs. Gene set analysis replicated previous findings (e.g., synapse, calcium signaling) and identified novel biological pathways including oxidative stress response, genomic integrity, kinase and small GTPase signaling. Furthermore, involvement of multiple SCZ candidate genes and biological pathways in the pathogenesis of SCZ was suggested in established SCZ-associated CNV loci. Our study shows the high genetic heterogeneity of SCZ and its clinical features and raises the possibility that genomic instability is involved in its pathogenesis, which may be related to the increased burden of de novo CNVs and variable expressivity of CNVs.


Schizophrenia Bulletin | 2015

Identification of Rare, Single-Nucleotide Mutations in NDE1 and Their Contributions to Schizophrenia Susceptibility

Hiroki Kimura; Daisuke Tsuboi; Chenyao Wang; Itaru Kushima; Takayoshi Koide; Masashi Ikeda; Yoshimi Iwayama; Tomoko Toyota; Noriko Yamamoto; Shohko Kunimoto; Yukako Nakamura; Akira Yoshimi; Masahiro Banno; Jingrui Xing; Yuto Takasaki; Mami Yoshida; Branko Aleksic; Yota Uno; Takashi Okada; Tetsuya Iidaka; Toshiya Inada; Michio Suzuki; Hiroshi Ujike; Hiroshi Kunugi; Tadafumi Kato; Takeo Yoshikawa; Nakao Iwata; Kozo Kaibuchi; Norio Ozaki

BACKGROUND Nuclear distribution E homolog 1 (NDE1), located within chromosome 16p13.11, plays an essential role in microtubule organization, mitosis, and neuronal migration and has been suggested by several studies of rare copy number variants to be a promising schizophrenia (SCZ) candidate gene. Recently, increasing attention has been paid to rare single-nucleotide variants (SNVs) discovered by deep sequencing of candidate genes, because such SNVs may have large effect sizes and their functional analysis may clarify etiopathology. METHODS AND RESULTS We conducted mutation screening of NDE1 coding exons using 433 SCZ and 145 pervasive developmental disorders samples in order to identify rare single nucleotide variants with a minor allele frequency ≤5%. We then performed genetic association analysis using a large number of unrelated individuals (3554 SCZ, 1041 bipolar disorder [BD], and 4746 controls). Among the discovered novel rare variants, we detected significant associations between SCZ and S214F (P = .039), and between BD and R234C (P = .032). Furthermore, functional assays showed that S214F affected axonal outgrowth and the interaction between NDE1 and YWHAE (14-3-3 epsilon; a neurodevelopmental regulator). CONCLUSIONS This study strengthens the evidence for association between rare variants within NDE1 and SCZ, and may shed light into the molecular mechanisms underlying this severe psychiatric disorder.


PLOS ONE | 2014

Factor Structure of the Japanese Version of the Edinburgh Postnatal Depression Scale in the Postpartum Period

Chika Kubota; Takashi Okada; Branko Aleksic; Yukako Nakamura; Shohko Kunimoto; Mako Morikawa; Tomoko Shiino; Ai Tamaji; Harue Ohoka; Naomi Banno; Tokiko Morita; Satomi Murase; Setsuko Goto; Atsuko Kanai; Tomoko Masuda; Masahiko Ando; Norio Ozaki

Background The Edinburgh Postnatal Depression Scale (EPDS) is a widely used screening tool for postpartum depression (PPD). Although the reliability and validity of EPDS in Japanese has been confirmed and the prevalence of PPD is found to be about the same as Western countries, the factor structure of the Japanese version of EPDS has not been elucidated yet. Methods 690 Japanese mothers completed all items of the EPDS at 1 month postpartum. We divided them randomly into two sample sets. The first sample set (n = 345) was used for exploratory factor analysis, and the second sample set was used (n = 345) for confirmatory factor analysis. Results The result of exploratory factor analysis indicated a three-factor model consisting of anxiety, depression and anhedonia. The results of confirmatory factor analysis suggested that the anxiety and anhedonia factors existed for EPDS in a sample of Japanese women at 1 month postpartum. The depression factor varies by the models of acceptable fit. Conclusions We examined EPDS scores. As a result, “anxiety” and “anhedonia” exist for EPDS among postpartum women in Japan as already reported in Western countries. Cross-cultural research is needed for future research.


Human Psychopharmacology-clinical and Experimental | 2012

Differential effects of diazepam, tandospirone, and paroxetine on plasma brain-derived neurotrophic factor level under mental stress

Ai Tamaji; Kunihiro Iwamoto; Yukiko Kawamura; Masahiro Takahashi; Kazutoshi Ebe; Naoko Kawano; Shohko Kunimoto; Branko Aleksic; Yukihiro Noda; Norio Ozaki

Serum brain‐derived neurotrophic factor (BDNF) levels are reduced in depressed patients, and successful antidepressant treatment leads to increases in BDNF levels. However, little is known about how psychotropic drugs affect the mechanism of the human response to mental stress. We investigated the influence of psychotropic drugs on plasma BDNF levels under mental stress using a driving simulator (DS) task.


Schizophrenia Research | 2014

Novel rare variants in F-box protein 45 (FBXO45) in schizophrenia

Chenyao Wang; Takayoshi Koide; Hiroki Kimura; Shohko Kunimoto; Akira Yoshimi; Yukako Nakamura; Itaru Kushima; Masahiro Banno; Naoko Kawano; Yuto Takasaki; Jingrui Xing; Yukihiro Noda; Akihiro Mouri; Branko Aleksic; Masashi Ikeda; Takashi Okada; Tetsuya Iidaka; Toshiya Inada; Nakao Iwata; Norio Ozaki

The ubiquitin ligase F-box protein 45 (FBXO45) is critical for synaptogenesis, neuronal migration, and synaptic transmission. FBXO45 is included in the 3q29 microdeletion region that confers a significant risk for schizophrenia, as shown by rare structural variant studies. Thus, FBXO45 is considered a prominent candidate for mediating schizophrenia pathogenesis. Here, we investigated rare, deleterious single nucleotide variants (SNVs) as well as small insertions and deletions (INDELs) in FBXO45 that may contribute to schizophrenia susceptibility. Using Sanger sequencing, we performed mutation screening in FBXO45 exon regions in 337 schizophrenia patients. Novel missense or nonsense variants were followed up with a genetic association study in an independent sample set of 601 schizophrenia patients and 916 controls, a case report for assessing the clinical consequence of the mutations, a pedigree study for measuring mutation inheritance in the probands family, bioinformatics analyses for evaluating mutation effect on protein structure and function, and mRNA expression analysis for examining mutation transcriptional influence on FBXO45 expression. One heterozygous, novel, and rare missense mutation (R108C) was identified in a single schizophrenia patient and in his healthy mother. At age 20, this patient was diagnosed with paranoid schizophrenia and carried some clinical features of 3q29 deletion phenotypes, including premorbid IQ decline. With follow-up genotyping, this mutation was not found in either the schizophrenia group (0/601) or the healthy control group (0/916). Bioinformatics analyses predicted that R108C probably pathologically impacted the structure and function of the FBXO45 protein. The relative expression of FBXO45 in SCZ case with R108C mutation was relatively low when compared to 50 schizophrenia patients and 52 healthy controls. The R108C mutation in FBXO45 is a rare variant with a modest effect on schizophrenia risk that may disrupt the structure and function of the FBXO45 protein. Our findings also suggest that FBXO45 may be a new attractive candidate gene for schizophrenia.


Scientific Reports | 2016

Mutation screening of GRIN2B in schizophrenia and autism spectrum disorder in a Japanese population

Yuto Takasaki; Takayoshi Koide; Chenyao Wang; Hiroki Kimura; Jingrui Xing; Itaru Kushima; Kanako Ishizuka; Daisuke Mori; Mariko Sekiguchi; Masashi Ikeda; Miki Aizawa; Naoko Tsurumaru; Yoshimi Iwayama; Akira Yoshimi; Yuko Arioka; Mami Yoshida; Hiromi Noma; Tomoko Oya-Ito; Yukako Nakamura; Shohko Kunimoto; Branko Aleksic; Yota Uno; Takashi Okada; Hiroshi Ujike; Jun Egawa; Hitoshi Kuwabara; Toshiyuki Someya; Takeo Yoshikawa; Nakao Iwata; Norio Ozaki

N-methyl-d-aspartate receptors (NMDARs) play a critical role in excitatory synaptic transmission and plasticity in the central nervous systems. Recent genetics studies in schizophrenia (SCZ) show that SCZ is susceptible to NMDARs and the NMDAR signaling complex. In autism spectrum disorder (ASD), several studies report dysregulation of NMDARs as a risk factor for ASD. To further examine the association between NMDARs and SCZ/ASD development, we conducted a mutation screening study of GRIN2B which encodes NR2B subunit of NMDARs, to identify rare mutations that potentially cause diseases, in SCZ and ASD patients (n = 574 and 152, respectively). This was followed by an association study in a large sample set of SCZ, ASD, and normal healthy controls (n = 4145, 381, and 4432, respectively). We identified five rare missense mutations through the mutation screening of GRIN2B. Although no statistically significant association between any single mutation and SCZ or ASD was found, one of its variant, K1292R, is found only in the patient group. To further examine the association between mutations in GRIN2B and SCZ/ASD development, a larger sample size and functional experiments are needed.


Scientific Reports | 2013

Definition and refinement of the 7q36.3 duplication region associated with schizophrenia

Branko Aleksic; Itaru Kushima; Tamae Ohye; Masashi Ikeda; Shohko Kunimoto; Yukako Nakamura; Akira Yoshimi; Takayoshi Koide; Shuji Iritani; Hiroki Kurahashi; Nakao Iwata; Norio Ozaki

Using a very high-resolution oligonucleotide array for copy number variant (CNV) screening of samples comprising schizophrenic patients, we detected a novel CNV within the critical region (NCBI36/hg18, Chr7: 158,630,410–158,719,410) previously shown to be associated with schizophrenia. We investigated the association between the novel CNV identified in the current study and schizophrenia. Three independent samples were used: (1) Screening set, 300 Japanese schizophrenic patients (53.28 ± 14.66 years); (2) Confirmation set, 531 schizophrenic patients (46.03 ± 12.15 years); and (3) 711 healthy controls (47.12 ± 11.03 years). All subjects enrolled in the study were Japanese. Chromosomal position was determined using fluorescence in situ hybridization. We identified a novel duplication within the region associated with schizophrenia identified on 7q36.3 that is adjacent to VIPR2 and is not associated with schizophrenia. In the Japanese population, the 35-kb region that harbors the common, novel CNV should be excluded from the region associated with schizophrenia on 7q36.3.


Neuropharmacology | 2018

Juvenile social defeat stress exposure persistently impairs social behaviors and neurogenesis

Akihiro Mouri; M. Ukai; Mizuki Uchida; Sho Hasegawa; Masayuki Taniguchi; Takahiro Ito; Hirotake Hida; Akira Yoshimi; Kiyofumi Yamada; Shohko Kunimoto; Norio Ozaki; Toshitaka Nabeshima; Yukihiro Noda

ABSTRACT Adverse juvenile experiences, including physical abuse, often have negative health consequences later in life. We investigated the influence of social defeat stress exposure as juveniles on neuropsychological behaviors, and the causal role of glucocorticoids in abnormal behaviors and impairment of neurogenesis in mice exposed to the stress. The juvenile (24‐day‐old) and adult (70‐day‐old) male C57BL/6J mice were exposed to social defeat stress induced by an aggressive ICR mouse. Social defeat stress exposure as juveniles, even for 1 day, induced persistent social avoidance to the unfamiliar ICR mouse in the social interaction test, but that was not observed in mice exposed to the stress as adults. Social avoidance by the stress exposure as juveniles for 10 consecutive days was observed, when the target mouse was not only unfamiliar ICR but also another C57BL/J mouse, but not an absent or an anesthetized ICR mouse. The stress exposure did not induce anxiety‐ and depression‐like behaviors in spontaneous locomotor activity, elevated plus‐maze test, marble‐burying test, forced swimming test, or sucrose preference test. Serum corticosterone levels increased immediately after the stress exposure. The hippocampal neurogenesis was suppressed 1 day and 4 weeks after the stress exposure. Administration of mifepristone, a glucocorticoid receptor antagonist, prior to each stress exposure, blocked the persistent social avoidance and suppression of neurogenesis. In conclusion, social avoidance induced by social defeat stress exposure as juveniles are more persistent than that as adults. These social avoidances are associated with suppression of hippocampal neurogenesis via glucocorticoid receptors. HighlightsSocial avoidance induced by social defeat stress exposure as juveniles are persistent.Anxiety is not changed by social defeat stress exposure as juveniles.Glucocorticoid activation is involved in the persistent social avoidance.Social avoidance is associated with suppression of hippocampal neurogenesis.

Collaboration


Dive into the Shohko Kunimoto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masashi Ikeda

Fujita Health University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nakao Iwata

Fujita Health University

View shared research outputs
Researchain Logo
Decentralizing Knowledge